Athanasios Angelakis

Athanasios Angelakis, Gabriele De Vito, Eleni-Myrto Trifylli et al.

Advanced fibrosis is a major determinant of liver-related morbidity in metabolic dysfunction-associated steatotic liver disease (MASLD). FIB-4 is widely used as a first-line non-invasive test, but its fixed formula may underuse diagnostic information contained in age, aspartate aminotransferase, alanine aminotransferase, and platelet count. We evaluated whether machine-learning-enhanced non-invasive testing (MLE-NIT) can improve advanced fibrosis detection while preserving this FIB-4 variable space. We used three biopsy-confirmed MASLD cohorts from China, Malaysia, and India (n=784). The Chinese cohort was split into 486 training and 54 internal validation/tuning patients; final performance was reported only on the Malaysian and Indian external cohorts. Models used five variables: age, FIB-4, aspartate aminotransferase, platelet count, and alanine aminotransferase. We compared FIB-4 with a shallow-deep neural network (s-DNN), TabPFN, and gpt-4o-2024-08-06. FIB-4 achieved external ROC-AUCs of 0.75 and 0.60 in Malaysia and India, respectively. TabPFN achieved 0.69 and 0.66, fine-tuned GPT-4o achieved 0.75 and 0.63, and the s-DNN achieved 0.77 and 0.67, respectively. The s-DNN contained only 354 trainable parameters, compared with 7,244,554 for TabPFN, yet provided a more balanced external operating profile. Calibration showed s-DNN Brier scores of 0.18 and 0.22, and permutation importance identified AST and FIB-4 as dominant variables. Compact non-linear MLE-NITs may enhance FIB-4-based fibrosis assessment without increasing clinical data requirements.

Athanasios Angelakis, Andrey Rass

Data augmentation (DA) enhances model generalization in computer vision but may introduce biases, impacting class accuracy unevenly. Our study extends this inquiry, examining DA's class-specific bias across various datasets, including those distinct from ImageNet, through random cropping. We evaluated this phenomenon with ResNet50, EfficientNetV2S, and SWIN ViT, discovering that while residual models showed similar bias effects, Vision Transformers exhibited greater robustness or altered dynamics. This suggests a nuanced approach to model selection, emphasizing bias mitigation. We also refined a "data augmentation robustness scouting" method to manage DA-induced biases more efficiently, reducing computational demands significantly (training 112 models instead of 1860; a reduction of factor 16.2) while still capturing essential bias trends.

Athanasios Angelakis, Amne Mousa, Micah L. A. Heldeweg et al.

Differentiating cardiogenic pulmonary oedema (CPE) from non-cardiogenic and structurally normal lungs in lung ultrasound (LUS) videos remains challenging due to the high visual variability of non-cardiogenic inflammatory patterns (NCIP/ARDS-like), interstitial lung disease, and healthy lungs. This heterogeneity complicates automated classification as overlapping B-lines and pleural artefacts are common. We introduce ZACH-ViT (Zero-token Adaptive Compact Hierarchical Vision Transformer), a 0.25 M-parameter Vision Transformer variant that removes both positional embeddings and the [CLS] token, making it fully permutation-invariant and suitable for unordered medical image data. To enhance generalization, we propose ShuffleStrides Data Augmentation (SSDA), which permutes probe-view sequences and frame orders while preserving anatomical validity. ZACH-ViT was evaluated on 380 LUS videos from 95 critically ill patients against nine state-of-the-art baselines. Despite the heterogeneity of the non-cardiogenic group, ZACH-ViT achieved the highest validation and test ROC-AUC (0.80 and 0.79) with balanced sensitivity (0.60) and specificity (0.91), while all competing models collapsed to trivial classification. It trains 1.35x faster than Minimal ViT (0.62M parameters) with 2.5x fewer parameters, supporting real-time clinical deployment. These results show that aligning architectural design with data structure can outperform scale in small-data medical imaging.